STENTiT is a medical device spin-off company from the Dutch Eindhoven University of Technology, focusing on the development of regenerative endovascular implants. These bioresorbable devices trigger a natural healing response by the circulating blood cells, in which the implant is being replaced by new vascular tissue to restore the artery from the inside-out.
Since the establishment of the company in 2017, STENTiT has received broad international recognition and awards for its high-potential approach, covering world leading stages. As the company is currently going through the next translational phases, STENTiT is on its way to fulfill its ambition to become the new standard in endovascular treatment, providing a life-lasting solution for millions of patients around the world.
Location: Netherlands, North Brabant, Eindhoven
Member count: 1-10
Total raised: $1.930396M
Founded date: 2017
Funding Rounds 1
| Date | Series | Amount | Investors | Deal News |
| 25.04.2022 | Seed | $1.930396M | - | finsmes.co... |
Mentions in press and media 6
| Date | Title | Description | Category | Author | Source |
| 30.12.2022 | Dutch-base... | The Netherlands is swiftly ris... | biotech f... | Vishal Sin... | siliconcan... |
| 28.12.2022 | Eindhoven-... | The city of Eindhoven in the N... | featured ... | Vishal Sin... | siliconcan... |
| 29.04.2022 | 12 Dutch-b... | Startups are an integral part ... | Dutch Star... | Vishal Sin... | siliconcan... |
| 25.04.2022 | Eindhoven-... | Eindhoven-based STENTiT, a med... | funding m... | Vishal Sin... | siliconcan... |
| 25.04.2022 | STENTiT Ra... | STENTiT, an Eindhoven, The Net... | Netherland... | - | finsmes.co... |
| 15.06.2021 | Dutch MedT... | STENTiT, a medical device comp... | - | - | aithority.... |